What changes are relevant to the future effectiveness of pharma?

Posted by on Dec 23, 2022 in Pharma | 0 comments

The global markets challenge the position of the pharmaceutical human businesses with different demands, like ways of pricing, patient orientation and ESG (environment, sustainability, and governance) to name a few. Some of these are kind of developments to which the industry has the competence to adapt easily, as history has witnessed.

What is new is the fact that the industry finds itself in an accumulation of characteristics acquired in its development since its origine. It has brought the industry in the current beneficial shape, its volume and routines of doing business. But that is up to now.

Read More

Pricing of medicines: a short sighted issue?

Posted by on May 13, 2016 in Blog, Pharma | 0 comments

Prices of medicines have gone down in the Netherlands for the last 20 years. The issue of pricing demonstrates how the different stakeholders in care keep each other as prisoner in the same context, rather than as co-stakeholder to the same goal: realizing better care to a lesser cost. Surely a provider of drugs can be hold at a distance to the other stakeholders, suggesting the pharma industry can be overpowered by payers, politicians or other stakeholders. It is a short sighted attitude. Innovation in care cannot do without close collaboration between stakeholder and a common way in dealing with costs and profits.

Read More

eHealth – the Introduction

Posted by on May 29, 2015 in Blog, eHealth | 0 comments

eHealth – The Introduction..
See in a short overview what ehealth actually is and what steps you may take to apply it to your proper organization.
Furthermore: learn about the ehealth thought lab that might direct you in the right direction to your healthcare future!

Read More

The third dimension in edetailing to pharma

Posted by on Feb 27, 2014 in Blog, health business, health care social media, Pharma | 0 comments

As doctors do use “mobile” devices now dominantly to get their information about new developments, the industry needs to adapt their way of informing their clients. Edetailing for the health industry is the norm, not a futuristic issue any more. Edetailing is not just about presenting information. It should also direct the industry’s ways of interaction with its clients. And, more so, to acknowledge that the end goal lies not just in using drugs or devices, but in improving care. That triggers fundamental change of how the industry needs to relate with its customers.

Read More